SOX7 Antibody
-
中文名稱：SOX7兔多克隆抗體
-
貨號：CSB-PA693928
-
規格：￥1100
-
圖片：
-
Gel: 10%SDS-PAGE, Lysate: 40 μg, Lane: Human lymphoma tissue, Primary antibody: CSB-PA693928(SOX7 Antibody) at dilution 1/1100, Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution, Exposure time: 2 minutes
-
-
其他：
產品詳情
-
Uniprot No.：
-
基因名：SOX7
-
別名：MGC10895 antibody; SOX 7 antibody; SOX 7 transcription factor antibody; sox7 antibody; SOX7 transcription factor antibody; SOX7_HUMAN antibody; SRY (sex determining region Y) box 7 antibody; SRY box 7 antibody; SRY sex determining region Y box 7 antibody; Transcription factor SOX 7 antibody; Transcription factor Sox-7 antibody; Transcription factor SOX7 antibody
-
宿主：Rabbit
-
反應種屬：Human,Mouse
-
免疫原：Fusion protein of Human SOX7
-
免疫原種屬：Homo sapiens (Human)
-
標記方式：Non-conjugated
-
抗體亞型：IgG
-
純化方式：Antigen affinity purification
-
濃度：It differs from different batches. Please contact us to confirm it.
-
保存緩沖液：-20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol
-
產品提供形式：Liquid
-
應用范圍：ELISA,WB
-
推薦稀釋比：
Application Recommended Dilution ELISA 1:2000-1:10000 WB 1:1000-1:5000 -
Protocols：
-
儲存條件：Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期：Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
-
用途：For Research Use Only. Not for use in diagnostic or therapeutic procedures.
產品評價
相關產品
靶點詳情
-
功能：Binds to and activates the CDH5 promoter, hence plays a role in the transcriptional regulation of genes expressed in the hemogenic endothelium and blocks further differentiation into blood precursors. May be required for the survival of both hematopoietic and endothelial precursors during specification. Competes with GATA4 for binding and activation of the FGF3 promoter. Represses Wnt/beta-catenin-stimulated transcription, probably by targeting CTNNB1 to proteasomal degradation. Binds the DNA sequence 5'-AACAAT-3'.
-
基因功能參考文獻：
- These results provide the first clue that miR-24-3p could play a role as an oncomiR in Lung cancer by regulating SOX7. PMID: 29231262
- we have identified an array of potential target genes of SOX7 and examined four of them for their roles in SOX7-mediated tumor suppression. We found that SOX7 could both activate and repress its target genes; and achieve its antiproliferative function through regulating multiple genes simultaneously. PMID: 29757932
- SOX7 transcription factor mediates PDGF-BB-induced IL-33 expression. PMID: 27150562
- Mechanistically, SOX7 was confirmed to be the downstream target of miR-616 in NSCLC cells. Forced expression of SOX7 prevented the promoting effects of miR-616 overexpression on the proliferation and metastasis of NSCLC cells, while knockdown of SOX7 reversed the inhibitory effects of miR-616 knockdown on the proliferation and metastasis of NSCLC cells. PMID: 28765960
- miR-9 was up-regulated and SOX7 was down-regulated in human non-small-cell lung cancer tissues and cell lines. PMID: 28266181
- The results indicate that SOX7 may inhibit the progression of liver carcinoma and that SOX7 downregulation may accurately predict poor prognosis in liver carcinoma patients. PMID: 28586005
- Consistent with bioinformatics predictions, SOX7 was correlated positively with AXIN2 and negatively with beta-catenin, suggesting that SOX7 and AXIN2 might play important roles as co-regulators through the Wnt-beta-catenin pathway in the breast tissue to affect the carcinogenesis process. PMID: 27188720
- SOX7 inhibits oncogenic beta-catenin-mediated transcription by disrupting the beta-catenin/BCL9 interaction. PMID: 29271667
- Overexpression of miR-935 inhibited SOX7 expression. PMID: 27697092
- The results suggest that miR-664 functions as an oncogene miRNA and has an important role in promoting human osteosarcoma cell invasion and migration by suppressing SOX7 expression. PMID: 26515813
- miR-595 played a critical role in carcinogenesis by suppression of SOX7. PMID: 27133048
- Aberrant methylation of the promoter regions of the SOX7 gene in patients with acute myeloid leukemias. PMID: 27459612
- miR-935 contributed to cell proliferation of gastric cancer through targeting SOX7. PMID: 27044823
- the HMG-box is a key domain of SOX7 for negatively regulating the Wnt/beta-catenin signaling pathway when functioning as a tumor suppressor in a glioma. PMID: 26944317
- The results provided unequivocal evidence for a novel tumor suppressor role of SOX7 in acute myeloid leukemia PMID: 25940713
- SOX7 plays an important inhibitory role in hepatocarcinogenesis, and might be a novel target for hepatocellular carcinoma therapy. PMID: 24816720
- Ectopic expression of miR-492 led to downregulation of SOX7 protein. PMID: 25407488
- Low SOX7 expression is associated with hepatocellular carcinoma. PMID: 25073511
- The expression of SOX7 correlates with tumor progression as a tumor suppressor, possibly through the Wnt/beta-catenin signaling pathway in ovarian cancers, suggesting that SOX7 may be a promising prognostic marker. PMID: 25297608
- Decreased expression of Sox7 correlates with the upregulation of the Wnt/beta-catenin signaling pathway and the poor survival of gastric cancer patients. PMID: 24788044
- miR-184 represents a potential onco-miR and plays an important role in HCC progression by suppressing SOX7 expression PMID: 24558429
- SOX7 acts as a tumor suppressor in breast cancer. PMID: 24012678
- SOX7 is a novel tumor suppressor gene silenced in the majority of NSCLC samples. PMID: 23557216
- Sox7 is a negative regulator of Wnt/beta-catenin signaling pathway through impeding the transcriptional machinery of beta-catenin/TCF/LEF-1 transcriptional complex, and the loss of expression may be involved in the pathogenesis of endometrial cancer. PMID: 23295859
- Association of SOX7 protein expression with clinical outcomes was evaluated. SOX7 mRNA expression was significantly down-regulated in lung adenocarcinoma compared with matched adjacent normal tissues. PMID: 22777918
- The methylation of the CpG island of the SOX7 gene can be used as a predictive factor for the development and prognosis of myelodysplastic syndrome patients. PMID: 22706399
- Data show that SOX7 is upregulated by aspirin and is involved in aspirin-mediated growth inhibition of human colorectal cancer SW480 cells. PMID: 22171135
- stable endoderm progenitors can be established from human ES cells by constitutive expression of SOX7 producing extraembryonic endoderm progenitors PMID: 18682240
- Sox7 is a tumor suppressor that functions as an independent checkpoint for beta-catenin transcriptional activity. Inactivation of Sox7 could promote the development of a majority of colorectal tumors and approximately half of prostate tumors. PMID: 18819930
- stable expression induces a stable expandable extra embryonic endoderm phenotype in hESCs PMID: 18940723
- SOX7, down-regulated in colorectal cancer, induces apoptosis and inhibits proliferation of colorectal cancer cells. PMID: 19108950
- gene expression, chromosome mapping, transactivation, interference with Wnt signaling PMID: 11691915
顯示更多
收起更多
-
亞細胞定位：Nucleus. Cytoplasm.
-
組織特異性：Widely expressed in adult and fetal tissues. Present both in mesenchymal and epithelial cells in some adult tissues, including colon. Tends to be down-regulated in prostate adenocarcinomas and colorectal tumors due to promoter hypermethylation.
-
數據庫鏈接：
Most popular with customers
-
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC, IF, FC
Species Reactivity: Human, Mouse, Rat
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-
